Cargando…
Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway: Galangin mitigates glucocorticoid-induced osteoporosis
Glucocorticoid-induced osteoporosis (GIOP), one of the most common and serious adverse effects associated with glucocorticoid administration, manifests as decreased bone formation and increased bone resorption, eventually culminating in bone loss. Galangin (GAL) is a flavonoid extracted from the med...
Autores principales: | Zeng, Chenying, Wang, Shan, Gu, Huimin, Chen, Fenglei, Wang, Ziming, Li, Jinteng, Xie, Zhongyu, Feng, Pei, Shen, Huiyong, Wu, Yanfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448057/ https://www.ncbi.nlm.nih.gov/pubmed/37365870 http://dx.doi.org/10.3724/abbs.2023063 |
Ejemplares similares
-
Alpinetin alleviates osteoporosis by promoting osteogenic differentiation in BMSCs by triggering autophagy via PKA/mTOR/ULK1 signaling
por: Zeng, Chenying, et al.
Publicado: (2022) -
Mitigation effect of galangin against aortic dysfunction and hypertrophy in rats with metabolic syndrome
por: Pakdeechote, Poungrat, et al.
Publicado: (2023) -
Glucocorticoid-induced osteoporosis
por: Briot, Karine, et al.
Publicado: (2015) -
Glucocorticoid-induced Osteoporosis
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2017) -
Identification of circRNA Expression Profiles in BMSCs from Glucocorticoid-Induced Osteoporosis Model
por: Chen, Zhipeng, et al.
Publicado: (2022)